345 research outputs found
Laboratory-confirmed respiratory infections as triggers for acute myocardial infarction and stroke: a self-controlled case series analysis of national linked datasets from Scotland
While acute respiratory tract infections can trigger cardiovascular events, the differential effect of specific organisms is unknown. This is important to guide vaccine policy.Using national infection surveillance data linked to the Scottish Morbidity Record, we identified adults with a first myocardial infarction or stroke from January 1, 2004 to December 31, 2014 and a record of laboratory-confirmed respiratory infection during this period. Using self-controlled case series analysis, we generated age- and season-adjusted incidence ratios (IRs) for myocardial infarction (n=1227) or stroke (n=762) after infections compared with baseline time.We found substantially increased myocardial infarction rates in the week after Streptococcus pneumoniae and influenza virus infection: adjusted IRs for days 1-3 were 5.98 (95% CI 2.47-14.4) and 9.80 (95% CI 2.37-40.5), respectively. Rates of stroke after infection were similarly high and remained elevated to 28 days: day 1-3 adjusted IRs 12.3 (95% CI 5.48-27.7) and 7.82 (95% CI 1.07-56.9) for S. pneumoniae and influenza virus, respectively. Although other respiratory viruses were associated with raised point estimates for both outcomes, only the day 4-7 estimate for stroke reached statistical significance.We showed a marked cardiovascular triggering effect of S. pneumoniae and influenza virus, which highlights the need for adequate pneumococcal and influenza vaccine uptake. Further research is needed into vascular effects of noninfluenza respiratory viruses
The EU in the AIIB: taming China’s influence from within. Egmont Security Policy Brief No. 86 May 2017
With the recent approval of the membership request of Belgium, Cyprus, Greece, Hungary, Ireland and Romania, the Asian Infrastructure Investment Bank (AIIB) will soon count 20 EU countries among its members. But how could the EU make the most of this presence in the bank? Apart from direct business opportunities for its private sector, there are strategic, long-term considerations too. It will be imperative that the EU exploit the link between the AIIB and the Belt and Road Initiative and ensure that the bank’s functioning remains consistent with EU development standards through a carefully co-ordinated voice within the institution
In-band time-to-live signaling system for combined DPSK/SCM scheme in OLS
We propose and validate experimentally a time-to-live (TTL) signaling system for an optical label swapping scheme based on 10-Gb/s differential phase-shift-keying (DPSK) packets and with 100-Mb/s subcarrier multiplexing (SCM) label. The proposed scheme allows fast packet discarding by using a 3-GHz subcarrier tone. DPSK payload has only a 2.4-dB power penalty at 10-9 bit-error rate after superimposing the SCM and TTL labeling signal
Evaluation of yield of currently available diagnostics by sample type to optimize detection of respiratory pathogens in patients with a community-acquired pneumonia
Background: For the detection of respiratory pathogens, the sampling strategy may influence the diagnostic yield. Ideally, samples from the lower respiratory tract are collected, but they are difficult to obtain. Objectives: In this study, we compared the diagnostic yield in sputum and oropharyngeal samples (OPS) for the detection of respiratory pathogens in patients with community-acquired pneumonia (CAP), with the objective to optimize our diagnostic testing algorithm. Methods: Matched sputum samples, OPS, blood cultures, serum, and urine samples were taken from patients (>18 years) with CAP and tested for the presence of possible respiratory pathogens using bacterial cultures, PCR for 17 viruses and five bacteria and urinary antigen testing. Results: When using only conventional methods, that is, blood cultures, sputum culture, urinary antigen tests, a pathogen was detected in 49·6% of patients (n = 57). Adding molecular detection assays increased the yield to 80%. A pathogen was detected in 77 of the 115 patients in OPS or sputum samples by PCR. The sensitivity of the OPS was lower than that of the sputum samples (57% versus 74%). In particular, bacterial pathogens were more often detected in sputum samples. The sensitivity of OPS for the detection of most viruses was higher than in sputum samples (72% versus 66%), except for human rhinovirus and respiratory syncytial virus. Conclusion: Addition of PCR on both OPS and sputum samples significantly increased the diagnostic yield. For molecular detection of bacterial pathogens, a sputum sample is imperative, but for detection of most viral pathogens, an OPS is sufficient
Targeted learning in observational studies with multi-valued treatments: An evaluation of antipsychotic drug treatment safety
We investigate estimation of causal effects of multiple competing
(multi-valued) treatments in the absence of randomization. Our work is
motivated by an intention-to-treat study of the relative cardiometabolic risk
of assignment to one of six commonly prescribed antipsychotic drugs in a cohort
of nearly 39,000 adults with serious mental illnesses. Doubly-robust
estimators, such as targeted minimum loss-based estimation (TMLE), require
correct specification of either the treatment model or outcome model to ensure
consistent estimation; however, common TMLE implementations estimate treatment
probabilities using multiple binomial regressions rather than multinomial
regression. We implement a TMLE estimator that uses multinomial treatment
assignment and ensemble machine learning to estimate average treatment effects.
Our multinomial implementation improves coverage, but does not necessarily
reduce bias, relative to the binomial implementation in simulation experiments
with varying treatment propensity overlap and event rates. Evaluating the
causal effects of the antipsychotics on three-year diabetes risk or death, we
find a safety benefit of moving from a second-generation drug considered among
the safest of the second-generation drugs to an infrequently prescribed
first-generation drug known for having low cardiometabolic risk
One-year efficacy and safety of routine prasugrel in patients with acute coronary syndromes treated with percutaneous coronary intervention
Objective: To investigate 1‑year outcomes with routine prasugrel treatment after acute coronary syndrome (ACS) in a large-scale registry. Methods: The Rijnmond Collective Cardiology Research registry is a prospective, observational study that enrolled 4,258 consecutive ACS patients treated with percutaneous coronary intervention (PCI) with 1‑year follow-up. Patients received prasugrel as first-choice antiplatelet agent, except for increased bleeding risk patients in which clopidogrel was recommended. Events were validated by an independent clinical endpoint committee. Results: A total number of 2,677 patients received prasugrel at discharge after the index event. Eighty-one percent of the target population was on prasugrel treatment at hospital discharge. At 1 year, the primary endpoint, a composite of all-cause mortality and myocardial infarction, occurred in 2.4% of patients receiving prasugrel. All-cause mortality occurred in 1.0%, myocardial infarction in 1.5%, target-vessel revascularisation in 3.1%, stent thrombosis in 0.6%, and stroke in 0.5% of the patients treated with prasugrel. Thrombolysis in Myocardial Infarction defined major bleeding episodes not related to coronary artery bypass grafting were observed in 1.4% of patients receiving prasugrel. Conclusions: In routine practice, a tailored approach of prasugrel prescription in ACS patients undergoing PCI, resulted in low ischaemic and low bleeding rates up to 1 year post PCI
- …